| 在心力衰竭治疗中非洋地黄类正性肌力作用药物再评介 |
| |
| 引用本文： | 黄震华. 在心力衰竭治疗中非洋地黄类正性肌力作用药物再评介[J]. 中国新药与临床杂志, 2003, 22(5): 303-309 |
| |
| 作者姓名： | 黄震华 |
| |
| 作者单位： | 上海第二医科大学附属第九人民医院,心血管病研究室,上海,200011 |
| |
| 摘 要： | 大量循证研究结果表明非洋地黄类正性肌力作用药物虽可改善心力衰竭病人血流动力学和缓解症状 ,但可增加心力衰竭病人的死亡率。本文提出了目前心力衰竭治疗中非洋地黄类正性肌力作用药物的使用指针 ,并对近年来非洋地黄类正性肌力作用药物的研究动向作了小结。
|
| 关 键 词： | 心力衰竭,充血性 强心药 死亡率 药物评价 |
| 文章编号： | 1007-7669(2003)05-0303-09 |
Reappraisal of non-digitalis positive inotropic drug in treatment of heart failure |
| |
| HUANG Zhen hua. Reappraisal of non-digitalis positive inotropic drug in treatment of heart failure[J]. Chinese Journal of New Drugs and Clinical Remedies, 2003, 22(5): 303-309 |
| |
| Authors: | HUANG Zhen hua |
| |
| Abstract: | A large number of evidence based researches showed that althoughnon digitalis positive inotropic drugs might improve hemodynamics and symptoms of heart failure patients, they might increase the mortality of heart failure. The current indication of non digitalis positive inotropic drug in the treatment of heart failure and research advance of non digitalis positive inotropic drug were summarized in this article. |
| |
| Keywords: | heart failure congestive carditonic agents mortality drug evalution |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
